Physician
Pathway Pediatrics, INC.
Pathway Pediatrics, INC. was paid $8.58M by Medicaid between Jan 2018 and Dec 2024, across 63 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 63% of everything it billed.
33Billing provider infoPATHWAY PEDIATRICS, INC.
SYLACAUGA, AL 35150
SYLACAUGA, AL 35150
33aNPI1083014658assigned 09/02/2014
33bProvider typePediatrics Physician
28Total paid$8.58M
24GClaims171,098
24DCodes billed63
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Alabama
Rank by total paid#19 of 199
Median peer was paid$702K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,284 | $574K | |
| 2019 | 31,394 | $1.06M | |
| 2020 | 18,231 | $916K | |
| 2021 | 24,223 | $1.38M | |
| 2022 | 23,872 | $1.42M | |
| 2023 | 29,233 | $1.66M | |
| 2024incomplete | 27,861 | $1.57M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 63% | 37,386 | 29,435 | $5.44M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 30,471 | 25,440 | $1.18M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.7% | 19,825 | 17,269 | $574K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.9% | 3,883 | 3,729 | $166K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.7% | 5,241 | 4,649 | $148K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.3% | 4,025 | 3,547 | $111K |
| 90670 | 1.1% | 2,353 | 2,131 | $98K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.1% | 1,778 | 1,537 | $91K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,067 | 1,768 | $83K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 8,288 | 3,533 | $77K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 3,065 | 2,724 | $71K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,099 | 2,533 | $66K |
51 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,192 | $61K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,875 | $47K |
| 90723 | <1% | 1,629 | $38K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,288 | $33K |
| 90686 | <1% | 2,604 | $31K | |
| 90461 | <1% | 549 | $28K | |
| 90680 | <1% | 1,017 | $27K | |
| 90651 | <1% | 453 | $26K | |
| 92551 | <1% | 6,281 | $25K | |
| 90648 | <1% | 2,543 | $25K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 4,411 | $22K |
| 90633 | <1% | 1,014 | $13K | |
| 99173 | <1% | 7,425 | $11K | |
| 90677 | <1% | 189 | $11K | |
| 90734 | <1% | 294 | $11K | |
| 80061 | Lipid panel | <1% | 648 | $8K |
| 81025 | <1% | 2,333 | $6K | |
| 36416 | <1% | 2,600 | $5K | |
| 90710 | <1% | 68 | $5K | |
| 90671 | <1% | 100 | $5K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 2,227 | $4K |
| 96127 | <1% | 1,761 | $3K | |
| 87807 | <1% | 437 | $3K | |
| 96119 | <1% | 68 | $2K | |
| 90715 | <1% | 147 | $2K | |
| 83655 | <1% | 160 | $2K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 125 | $2K |
| 90696 | <1% | 84 | $2K | |
| 96120 | <1% | 68 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 20 | $1K |
| 90716 | <1% | 25 | $1K | |
| 85018 | <1% | 530 | $1K | |
| 90707 | <1% | 27 | $887.90 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 46 | $886.73 |
| 90656 | <1% | 69 | $874.05 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 137 | $861.16 |
| 90700 | <1% | 64 | $683.04 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 17 | $428.32 |
| 99177 | <1% | 27 | $337.61 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 226 | $321.34 |
| 90647 | <1% | 16 | $316.64 | |
| 99401 | <1% | 35 | $281.45 | |
| 90688 | <1% | 14 | $249.76 | |
| 81003 | <1% | 75 | $206.90 | |
| 81002 | <1% | 57 | $143.61 | |
| 99072 | <1% | 211 | $140.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 19 | $121.08 |
| 96161 | <1% | 59 | $101.33 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 182 | $55.20 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 21 | $2.82 |
| 99080 | <1% | 150 | $0.01 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSAWYER, LESLIE (PRESIDENT / PEDIATRICIAN)